Literature DB >> 30032237

How well does the process of screening and diagnosis work for HIV-infected persons identified with presumptive tuberculosis who are attending HIV care and treatment clinics in Harare city, Zimbabwe?

Kudakwashe C Takarinda1,2, Regis Choto1, Charles Sandy1, Tsitsi Apollo1, Clemence Duri3, Freeman Dube4, Amon Mpofu4, Collins Timire1,2, Owen Mugurungi1, Victor Makaza4, Roy Tapera5, Anthony D Harries2,6.   

Abstract

Background: Intensified TB case finding is recommended for all HIV-infected persons regularly attending HIV care and treatment clinics. The authors aimed to determine how well this system worked among HIV-infected patients diagnosed with presumptive TB in 14 health facilities of Harare province, Zimbabwe, between January and December 2016.
Methods: Retrospective review using routine programme records.
Results: Of 47 659 HIV-infected persons enrolled in HIV care, 102 were identified with presumptive TB through the programmatic electronic database. Of these, 23% (23/102) were recorded in presumptive TB registers and, of these 65% (15/23) were traced to laboratory registers. Of 79 patients not recorded in presumptive TB registers, 9% (7/79) were traced to laboratory registers. Of 22 patients in the laboratory register, all had negative sputum smears for acid-fast bacilli and 45% (10/22) had Xpert MTB/RIF assays with one positive result. Six patients altogether started anti-tuberculosis treatment, the median time from presumptive tuberculosis diagnosis to treatment being 12 days. The only significant risk factor for loss-to-follow-up between presumptive TB diagnosis and laboratory registration was not being recorded in presumptive TB registers. Conclusions: Follow-up mechanisms for presumptive TB cases diagnosed in HIV care clinics in Harare city need strengthening, particularly through improved documentation in presumptive TB registers and better Xpert MTB/RIF use.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30032237     DOI: 10.1093/trstmh/try073

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  Eliminating tuberculosis by 2035: tackling the financial barriers at all stages of the cascade of care.

Authors:  C Timire; C Sandy; A D Harries
Journal:  Int J Tuberc Lung Dis       Date:  2019-11-01       Impact factor: 2.373

2.  Improving sputum collection processes to increase tuberculosis case finding among HIV-positive persons in Botswana.

Authors:  U Mathebula; C Emerson; T Agizew; S Pals; R Boyd; A Mathoma; J Basotli; G Rankgoane-Pono; C Serumola; A Date; A F Auld; A Finlay
Journal:  Public Health Action       Date:  2020-03-21

3.  Ensuring that Xpert® MTB/RIF is used to its maximum potential.

Authors:  A D Harries; C Timire; K C Takarinda; C Sandy
Journal:  Int J Tuberc Lung Dis       Date:  2019-09-01       Impact factor: 2.373

4.  Trend analysis of tuberculosis case notifications with scale-up of antiretroviral therapy and roll-out of isoniazid preventive therapy in Zimbabwe, 2000-2018.

Authors:  Kudakwashe C Takarinda; Anthony D Harries; Tsitsi Mutasa-Apollo; Charles Sandy; Regis C Choto; Simbarashe Mabaya; Cephas Mbito; Collins Timire
Journal:  BMJ Open       Date:  2020-04-06       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.